Maher BMC Public Health 2010, 10:394 http://www.biomedcentral.com/1471-2458/10/394 3. Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science 2000, 287:607-14. 4. Joint United Nations Programme on HIV/AIDS: 2008 Report on the global AIDS epidemic. Geneva 2008. 5. Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V: PLoS Pathogens 2005, 1(1):1-7. e5 6. Sutherland I: Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Advances in Tuberculosis Research 1976, 19:1-63. 7. National Tuberculosis Institute Bangalore: Tuberculosis in a rural population of South India: a five-year epidemiological study. Bulletin of the World Health Organization 1974, 51:473-88. 8. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M, WHO Global Surveillance and Monitoring Project: Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. Journal of the American Medical Association 1999, 282:677-86. 9. Morgan D, Mahe C, Mayanja B, Whitworth JA: Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. British Medical Journal 2002, 324:193-6. 10. Comstock GW, Cauthen GM: Epidemiology of tuberculosis. In Tuberculosis A Comprehensive International Approach Volume 66. Edited by: Reichman LB, Hershfield ES. New York: Marcel Dekker Inc; 1993:23-48. 11. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008, 22:1897-1908. 12. Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bulletin WHO 2002, 80:217-227. 13. World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO Report 2009. Geneva 2009. 14. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Corbett EL, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine 2003, 163:1009-21. 15. Dye C, Harries A, Maher D, Hosseini S, Nkhoma W, Salaniponi F: Tuberculosis. In Disease Morbidity and Mortality in sub-Saharan Africa Edited by: Feachem R. Washington DC: World Bank; 2006. 16. World Health Organization: A strategic framework to decrease the burden of TB/HIV (WHO/CDS/TB/2002.296). Geneva 2002. 17. World Health Organization: An analysis of interaction between tuberculosis and HIV/AIDS programmes in sub-Saharan Africa. (WHO/CDS/TB/2001.294). Geneva 2001. 18. Merson MH, O'Malley J, Serwadda D, Apisuk C: The history and challenge of HIV prevention. Lancet 2008, 372:475-88. 19. Padian NS, Buvé A, Balkus J, Serwadda D, Cates W: Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 2008, 372:585-599. 20. De Cock KM, Gilks CF, Lo YR, Guerma T: Can antiretroviral therapy eliminate HIV transmission? Lancet 2008. DOI:10.1016/S0140- 6736(08)61732-8 21. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2008, 373:48-57. 22. Maher D, Espinal M, Raviglione M: Tuberculosis. In Oxford Textbook of Public Health Fifth edition. Edited by: Detels et al. Oxford: Oxford University Press; 2009. 23. Maher D, Raviglione M: The history of the DOTS strategy: achievements and perspectives. In Tuberculosis Edited by: Schaaf S, Zumla A. London: Elsevier; 2009. 24. Rouillon A, Perdrizet S, Parrot R: Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976, 57:275-299. 25. Coates TJ, Richter L, Caceres C: Behavioural strategies to reduce HIV transmission: how to make them better. Lancet 2008, 372:669-84. 26. Wodak A: The role of harm reduction in controlling HIV among injecting drug users. AIDS 2008, 22(Suppl 2):S81-92. 27. World Health Organization: WHO policy on TB infection control in health- care facilities, congregate settings and households. WHO/HTM/TB/2009.419 Geneva 2009. 28. World Health Organization: Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. Geneva 1999. Page 10 of 11 29. Alliance for Microbicide Development: Microbicide candidates in ongoing clinical trials 2009 [http://www.microbicide.org]. 30. World Health Organization: SEX-RAR Guide. The rapid assessment and response guide on psychoactive substance use and sexual risk behaviour. Geneva 2002. 31. Mellenekamp MA, Jerrells TR: Effects of ethanol consumption on susceptibility to pulmonary and gastrointestinal infections. Alcohol Clin Exp Res 1996, 20(suppl):192A-5A. 32. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 2007, 167:335-342. 33. Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A, Serwadda D, Gray RH, Grosskurth H, Habbema JD, Hayes RJ: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai and Masaka intervention trials. J Infect Dis 2005, 191(suppl 1):S168-78. 34. Harries AD, Billo N, Kapur A: Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Transactions of the Royal Society of Tropical Medicine and Hygiene 2009, 103:1-2. 35. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006, 3:e262. 36. Liu AY, Grant RM, Buchbinder SP: Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA 2006, 296:863-65. 37. World Health Organization: Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva 2006. 38. World Health Organization: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access; recommendations for a public health approach. Geneva 2006. 39. Fisher M, Benn P, Evans B, Pozniak A, Jones M, MacLean S, Davidson O, Summerside J, Hawkins DC, Clinical Effectiveness Group (British Association for Sexual Health and HIV): UK guideline for the use of post- exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 2006, 17:81-92. 40. World Health Organization: Preventive Therapy against Tuberculosis in People Living with HIV. Weekly Epidemiological Record 1999, 74:385-98. 41. Velasco-Hernandez JX, Gershengorn HB, Blower SM: Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2002, 2:487-93. 42. Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368:531-36. 43. Garnett GP, Baggaley RF: Treating our way out of the HIV pandemic: could we, would we, should we? Lancet 2008. DOI:10.1016/S0140- 6736(08)61698-0 44. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC: International Standards for Tuberculosis Care. Lancet Infectious Diseases 2006, 6:710-25. 45. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg H, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Journal of the American Medical Association 1994, 271:698-702. 46. World Health Organization: Towards universal access: scaling up priority HIV/ AIDS interventions in the health sector. Progress report 2009. Geneva 2000. 47. Rosen S, Fox M, Gill C: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review PLoS Medicine 2007, 10:e29. 48. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF: The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antiviral Therapy 2008, 13(suppl 2):1-13. 49. Wright A, Zignol M, Van Deun A, Falzon D, Ruesch Gerdes S, Feldmann K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M: Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009, 373:1861-73. 50. World Health Organization: Use of antiretroviral therapy in resource-limited countries in 2007: distribution and uptake of first- and second-line regimens. Geneva 2008. 51. World Health Organization and Stop TB Partnership: The Global Plan to Stop TB, 2006-2015. Geneva 2006.